HIV/AIDS Topics Top 12 HIV and Hepatitis Stories of 2012
- Details
- Category: HIV Treatment
- Published on Thursday, 27 December 2012 00:00
- Written by Liz Highleyman
In our last issue for 2012, HIVandHepatitis.com reviews some the year's major HIV and viral hepatitis news highlights. On the HIV front, U.S. treatment guidelines recommended antiretroviral therapy (ART) for all HIV positive people, Truvada was approved for pre-exposure prophylaxis (PrEP), and HIV criminalization and cure research were highlighted at the International AIDS Conference in July. Promising findings were reported for several interferon-free oral regimens for hepatitis C, experimental tuberculosis (TB) drugs showed good results, and the Affordable Care Act remained on track.
Lubricants for Sex Can Damage Cells, but Did Not Increase HIV Risk in Lab Study
- Details
- Category: HIV Prevention
- Published on Tuesday, 11 December 2012 00:00
- Written by Liz Highleyman
Certain sexual lubricant formulations are toxic to cells and can cause damage to the epithelial lining of the vagina or rectum, but this did not appear to facilitate HIV infection, researchers reported in the November 7, 2012, edition of the open-access journal PLoS ONE. 
Coverage of 11th International Congress on Drug Therapy in HIV Infection
- Details
- Category: HIV Treatment
- Published on Saturday, 17 November 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 11th International Congress on Drug Therapy in HIV Infection (HIV11), November 11-15, 2012, Glasgow, Scotland.
Conference highlights include experimental antiretroviral drugs, ART strategies, manging side effects, HIV-related non-AIDS conditions, treatment as prevention and PrEP, HIV/HCV coinfection, and the search for a cure for HIV.
HIVandHepatitis.com HIV11 conference section
11/17/12
UNAIDS Reports Progress, PEPFAR Blueprint Looks Towards AIDS-free Generation
- Details
- Category: HIV Treatment
- Published on Friday, 30 November 2012 00:00
- Written by Liz Highleyman
The latest global report from UNAIDS, release ahead of World AIDS Day on December 1, highlights progress in stemming the epidemic, including lower rates of new infection in many countries and a growing proportion of HIV positive people on antiretroviral treatment. Continued progress requires adequate funding, however. To that end, U.S. Secretary of State Hillary Clinton this week released a "Blueprint" detailing recent advances and future plans for achieving a generation free from AIDS.
Immune Activation Raised HIV Risk in CAPRISA Trial, but Some Develop Protective Antibodies
- Details
- Category: HIV Prevention
- Published on Tuesday, 06 November 2012 00:00
- Written by Liz Highleyman
Women in the CAPRISA 004 vaginal gel trial who showed evidence of prior immune activation had an increased likelihood of becoming infected with HIV, researchers recently reported. Another CAPRISA analysis found that 2 women exhibitedbroadly cross-neutralizing antibodies targeting a newly emergent antigen on HIV's envelope -- a discovery that could advance vaccine research.
Web Design and Development by